Latest Competition News

Tinybeans Group announces a leadership reshuffle with Tracy Cho as Interim CEO and Rebecca White joining the Board, sharpening its focus on expanding in the lucrative U.S. family market.

Mayne Pharma has announced a planned leadership transition with CFO Aaron Gray stepping up as CEO, succeeding Shawn Patrick O’Brien who will remain as an advisor during the handover.

VEEM Limited reports half-year revenue close to guidance with improved cash flow, offset by a significant $24.8 million non-cash impairment tied to its gyro product upgrade. The transition to the new Mark III gyro design has temporarily stalled sales as customers await delivery.

EMVision Medical Devices reported a $3.97 million loss for H1 2026, up 11% year-on-year, driven by increased share-based payments and expanded clinical activities. The company secured a $3 million government grant to advance stroke diagnosis in regional Australia.

Symal Group Limited reported a robust half-year performance with revenues climbing 24.6% to $504.2 million and announced key acquisitions to bolster its infrastructure footprint. The company also secured $300 million in new debt facilities to support its expansion plans.

Adairs Limited reported a solid 5.9% increase in sales for the half year ended December 2025, driven by strong brand performances, especially Mocka. However, underlying EBIT declined 9.1% due to margin pressures and rising costs, while the company declared a fully franked interim dividend.

Praemium Limited reported a robust half-year performance with a 69.5% jump in net profit and a 9.6% rise in funds under administration, completing the OneVue platform transition and acquiring AI specialist Technotia Laboratories.

Lindsay Australia Limited reported a robust 24.9% increase in revenue for the half-year ending December 2025, driven by its strategic acquisition of SRT Logistics and strong divisional performances. However, profit after tax declined 11.7%, reflecting competitive pricing and integration expenses.

Stanmore Resources Limited posted a net loss of US$47.2 million for 2025, impacted by a 21% revenue decline due to lower coal prices despite record production and cost efficiencies. The company declared a fully franked final dividend of US 8.9 cents per share.

nib holdings limited reported a stable net profit of $82.9 million for the half year ended 31 December 2025, supported by 6% revenue growth and disciplined expense management. The Board declared a fully franked interim dividend of 13.0 cents per share.

IMDEX Limited has reported its strongest first half ever, with revenue climbing 16% to $247 million, driven by robust market share gains and key acquisitions that broaden its mining technology portfolio.

Mesoblast Limited is set to release its half-year financial results and operational update, spotlighting its FDA-approved cell therapy and expanding international partnerships.